A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.Camille N. Abboud, Farhad Ravandi, Charalambos Andreadis et al.|Journal of Clinical Oncology|2018Cited by 3